期刊
CELL REPORTS
卷 19, 期 10, 页码 2102-2115出版社
CELL PRESS
DOI: 10.1016/j.celrep.2017.05.050
关键词
-
类别
资金
- NCI [R37CA064786, U54CA143836]
- Department of Defense Breast Cancer Research Program [W81XWH0810736]
- Breast Cancer Research Foundation
- Bissell laboratory
- Brazilian National Research Council (CNPq) [465699/2014-6]
- Sao Paulo State Research Funding Agency (FAPESP) [2014/50938-8]
- FAPESP [2014/10492-0, 2014/25832-1]
- INFABIC
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/50938-8] Funding Source: FAPESP
Nuclear actin (N-actin) is known to participate in the regulation of gene expression. We showed previously that N-actin levels mediate the growth and quiescence of mouse epithelial cells in response to laminin-111 (LN1), a component of the mammary basement membrane (BM). We know that BM is defective in malignant cells, and we show here that it is the LN1/N-actin pathway that is aberrant in human breast cancer cells, leading to continuous growth. Photobleaching assays revealed that N-actin exit in nonmalignant cells begins as early as 30 min after LN1 treatment. LN1 attenuates the PI3K pathway leading to upregulation of exportin-6 (XPO6) activity and shuttles actin out of the nucleus. Silencing XPO6 prevents quiescence. Malignant cells are impervious to LN1 signaling. These results shed light on the crucial role of LN1 in quiescence and differentiation and how defects in the LN1/ PI3K/XPO6/N-actin axis explain the loss of tissue homeostasis and growth control that contributes to malignant progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据